WHO-GMP Certified — Effective Type 2 Diabetes Management
Helps Control Blood Sugar For A Healthier Tomorrow
Sitagliptin Tablets IP 100 mg (Sitagliptin-100) are oral antidiabetic tablets used for the management of Type 2 Diabetes Mellitus. As a DPP-4 inhibitor, Sitagliptin improves glycaemic control by increasing incretin levels that regulate blood sugar. Mediocon Inc supplies these tablets under WHO-GMP certified manufacturing conditions.
Available in standard pharma-grade packaging. Export-ready with complete documentation including COA, MSDS, and regulatory support.